Cargando…
High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer
BACKGROUND: Although notable therapeutic and prognostic benefits of compound kushen injection (CKI) have been found when it was used alone or in combination with chemotherapy or radiotherapy for triple-negative breast cancer (TNBC) treatment, the effects of CKI on TNBC microenvironment remain largel...
Autores principales: | Liu, Xinkui, Wu, Yang, Zhang, Yingying, Bu, Dechao, Wu, Chao, Lu, Shan, Huang, Zhihong, Song, Yurong, Zhao, Yi, Guo, Fengying, Ye, Peizhi, Fu, Changgeng, Shen, Liangliang, Zhang, Jingyuan, Wang, Haojia, Duan, Xianchun, Wu, Jiarui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484800/ https://www.ncbi.nlm.nih.gov/pubmed/34604090 http://dx.doi.org/10.3389/fonc.2021.747300 |
Ejemplares similares
-
An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification
por: Lu, Shan, et al.
Publicado: (2022) -
Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer
por: Liu, Xinkui, et al.
Publicado: (2022) -
An Advanced Systems Pharmacology Strategy Reveals AKR1B1, MMP2, PTGER3 as Key Genes in the Competing Endogenous RNA Network of Compound Kushen Injection Treating Gastric Carcinoma by Integrated Bioinformatics and Experimental Verification
por: Zhou, Wei, et al.
Publicado: (2021) -
Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology
por: Zhou, Wei, et al.
Publicado: (2020) -
Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology
por: Zhou, Wei, et al.
Publicado: (2020)